Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 27, 2019
Notable has expanded its management team with Hiroomi Tada as Chief Medical Officer and Lloyd Mackenzie as Chief Development Officer.
read more
Wednesday, November 04, 2020
Nostrum Laboratories is voluntarily recalling two lots of Metformin HCl Extended Release Tablets, USP 500 mg to the consumer level.
read more
Thursday, December 17, 2015
Nostrum Laboratories, a wholly-owned subsidiary of Nostrum Pharmaceuticals, LLC and a fully-integrated specialty pharmaceutical company principally engaged in the development and commercialization of highly specialized, difficult to formulate, ...
read more
Nosopharm and Evotec announced their partnership aimed at advancing NOSO-502, to the clinical stage, as well as developing a second-generation Odilorhabdin drug candidate.
read more
Thursday, January 17, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry today announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development ...
read more
Thursday, October 24, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, today announced that it has changed its name to Norwich Pharma Services. The new name and brand identity ...
read more
Tuesday, December 11, 2012
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, announced today that the company has been recognized as Manufacturer of the Year by the Chenango County ...
read more
Wednesday, February 25, 2026
NorthX Biologics and Demeetra announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full freedom to operate and no additional IP-related costs, together with advanced cell line development technologies ...
read more
GenomOncology announces Northwestern Memorial Healthcare has chosen the Pathology Workbench system as part of its clinical analysis process for their latest Oncomine Comprehensive NGS Assay.
read more
Northwest Biotherapeutics and Advent BioServices, a leading contract development and manufacturing organization (CDMO) based in the UK, jointly announce that a MIA license has been approved and issued by the Medicines and Healthcare Products ...
read more
Thursday, November 21, 2024
NorthStar Medical Radioisotopes announced the signing of a strategic Master Supply Agreement with Cellectar Biosciences, Inc. under which Cellectar will acquire and integrate NorthStar’s n.c.a. Ac-225 into Cellectar’s proprietary Phospholipid Ethers ...
read more
Tuesday, November 15, 2022
NorthStar Medical Radioisotopes announced a significant expansion of its business platform with the formation of a new, patient-focused Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) services unit.
read more
NorthStar Medical Radioisotopes announced completion of construction on its 20,000 square foot Mo-99 processing facility in Beloit, Wis., with equipment installation currently underway.
read more
Tuesday, December 10, 2024
NorthStar Medical Radioisotopes, LLC, and PeptiDream Inc. announced that PeptiDream’s wholly owned subsidiary PDRadiopharma Inc. has entered into a strategic collaboration with NorthStar for the development, production, and commercialization of ...
read more
Wednesday, November 22, 2023
In a strategic move, private equity firm NorthEdge has infused capital into Torbay Pharmaceuticals (Torbay), a leading sterile injectable contract manufacturer and license holder. This investment comes as Torbay transitions into its next phase of ...
read more